What we’re reading, October 7, 2016: providers brace for Hurricane Matthew; lead exposure in children has dropped; and most physicians would not apologize to their patient after a mistake.
Healthcare providers in the Southeast are preparing for the impact of Matthew, the Category 3 hurricane due to make landfall today. Amidst dire warnings of potentially devastating winds and storm surges, many hospitals are stocking up on supplies, preparing for an influx of patients, and canceling elective appointments. However, other hospitals on vulnerable, flood-prone barrier islands are evacuating patients and all but a handful of employees. Matthew already battered Haiti while it was a Category 4 storm, killing at least 271 people; officials fear it could worsen the cholera epidemic there.
Data released by the CDC this week indicate that lead exposure in children has fallen significantly, but racial disparities persist. From 1988-1994 to 2007-2014, the rate of children age 1 to 5 with elevated blood lead levels had dropped from 25.6% to 1.9%. However, the data for 2007-2014 show that black children (4.0%) were twice as likely as white children (1.9%) and more than 3 times as likely as Hispanic children (1.1%) to have high levels of lead in their blood. Because lead paint was outlawed in 1978, children at or below the poverty line living in older housing are most at risk of lead exposure.
A survey of primary care physicians found that more than half would not apologize to a patient after making a mistake that put the patient’s health at risk. In hypothetical situations of delayed care or system breakdown, 53.1% and 61.4% of physicians, respectively, said they would offer no disclosure whatsoever. The rest were split between full disclosure (taking personal responsibility) and partial disclosure (blaming the system). Surprisingly, the perceived seriousness of the error and the extent to which the respondents felt responsible for it were likely to predict the level of disclosure, not the anticipation of a lawsuit.
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More